Rheumatology Current Events | Rheumatology News | 3
|
|
|
Sort By:
Page Views | Date |
Efficacy of glucosamine, chondroitin sulfate may depend on level of osteoarthritis pain
The popular dietary supplements glucosamine and chondroitin sulfate proved no better than a placebo in relieving osteoarthritis knee pain in most participants of a major national trial. view more (2006-02-23)
ESA astronaut Claudie Haigneré appointed minister
Claudie Haigneré, the ESA astronaut, has been appointed to the post of Minister for Research and New Technologies in the French government announced yesterday. Claudie Haigneré, 45, with an outstanding `cursus honoris`, a doctor with a specialisation in rheumatology and a Ph.D in neurosciences, was selected in 1985 as a candidate... view more... (2002-06-18)
Pregnant women with lupus face higher risk of complications and death
Women with systemic lupus who become pregnant are at significantly greater risk for death or other medical complications than are pregnant women without lupus, Duke University Medical Center researchers have found in a nationwide study of more than 18 million women. view more (2006-11-13)
Impact of cannabis on bones changes with age, study finds
Scientists investigating the effects of cannabis on bone health have found that its impact varies dramatically with age. view more (2009-08-14)
Bioengineered tissue implants regenerate damaged knee cartilage
Knee cartilage injuries can be effectively repaired by tissue engineering and osteoarthritis does not stop the regeneration process concludes research led by scientists at the University of Bristol. view more (2006-07-05)
Pain thresholds linked to inflammation and sleep problems in arthritis patients
Despite recent advances in anti-inflammatory therapy, many rheumatoid arthritis (RA) patients continue to suffer from pain. view more (2009-10-29)
Electronic health record triples rate of osteoporosis screenings
Use of the Electronic Health Record tripled the rate of osteoporosis screenings in women who are at risk for the disease, according to a study conducted recently by a team of Geisinger Health System researchers. view more (2006-12-08)
Discovery of a 'molecular switch' could lead to new ways of treating infection, including MRSA
The discovery of a 'molecular switch' could lead to new ways of treating infections such as MRSA, and inflammatory diseases like arthritis. view more (2005-04-26)
3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis
Three new studies have individually shown the anti-TNF (tumour necrosis factor) therapy etanercept to be effective, with a good safety profile, in children under four years of age with juvenile idiopathic arthritis (JIA). view more (2009-06-12)
Media invitation from the European League Against Rheumatism (EULAR)
An invitation from the European League Against Rheumatism (EULAR) to report on Europe's most important conference on arthritis and rheumatism. The Annual European Congress of Rheumatology Lisbon Congress Centre, Lisbon, Portugal, 18-21 June 2003 www.eular.org view more (2003-02-28)
Golimumab significantly reduced signs and symptoms of ankylosing spondylitis
More than half of patients receiving monthly subcutaneous (SC) injections of golimumab (CNTO 148) 50 mg and 100 mg experienced significant and sustained improvements in the signs and symptoms of active ankylosing spondylitis, according to Phase 3 study results presented at the American College of Rheumatology (ACR) annual meeting. view more (2007-11-08)
New treatment effective for patients with shoulder pain
Inflammation of a tendon triggered by calcium deposits, or calcific tendinitis, can effectively be treated with a simple and cost effective percutaneous method according to a recent study conducted by researchers from the Hospital de Basurto in Bilbao, Spain. view more (2007-09-25)
Mayo researchers note that stronger leg muscles can protect against knee osteoarthritis
Stronger quadriceps muscles in the legs can help protect against cartilage loss behind the kneecap, according to Mayo Clinic researchers presenting preliminary study data at the American College of Rheumatology Annual Meeting on Nov. 15. view more (2006-11-15)
Researchers link inflammatory diseases to increased cardiovascular risk
Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease. view more (2009-09-02)
Tocilizumab study offers new hope for children with arthritis
A new study has confirmed significant improvements after treatment with tocilizumab amongst children with systemic juvenile idiopathic arthritis (sJIA), who do not tolerate or have an inadequate response to conventional therapies. view more (2006-06-23)
Mayo Clinic study predicts cardiovascular disease risk for rheumatoid arthritis patients
People with rheumatoid arthritis have a higher risk for developing heart disease than the general population; however, it is difficult to identify which patients are at increased risk. view more (2007-11-08)
Investigational study of ustekinumab in the treatment of psoriatic arthritis published
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomized, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA). view more (2009-02-12)
New long-term data suggests Abatacept treatment
New data from the long-term extension of the AIM (Abatacept in Inadequate responders to Methotrexte) trial, announced today at the Annual European Congress of Rheumatology, suggests the selective T-cell co-stimulation modulator abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis patients with an... view more... (2006-06-22)
Two drugs may stabilize plaques in atherosclerosis
Two drugs that a Wake Forest University School of Medicine research team has been investigating for lupus for several years may stabilize atherosclerotic plaque in the walls of arteries and help avert heart attacks and strokes. view more (2006-11-13)
TNF-Alpha Blocker Infliximab Highly Effective For Patients With Ankylosing Spondylitis
BERLIN, Germany - 6 April 2002 -- For the first time, there is a therapy that can significantly reduce disease activity for the majority of patients with ankylosing spondylitis (AS), a chronic inflammatory rheumatic disease that often leads to stiffening and subsequent fusion of the spine. The study, published in the April 6 issue of "The... view more... (2002-04-05)
|
|
|
|
Sort By:
Page Views | Date |
|
